CRTX Key Stats
|Revenue (Quarterly YoY Growth)||43.10%|
|EPS Diluted (TTM)||0.3258|
|EPS Diluted (Quarterly YoY Growth)||520.0%|
|Net Income (TTM)||10.80M|
|Gross Profit Margin (Quarterly)||76.46%|
|Profit Margin (Quarterly)||17.84%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
- Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa noodls Nov 20
- Cornerstone Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript Nov 7
- CORNERSTONE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements Nov 7
- Cornerstone Therapeutics, Inc. (CRTX) Tops Q3 EPS by 19c, Sales Beat Street Insider Nov 7
- Q3 2013 Cornerstone Therapeutics Inc. Earnings Release - Before Market Open Nov 7
- Cornerstone Therapeutics Reports Third Quarter 2013 Financial Results Marketwired Nov 7
- Trading Radar for 11/07: Disney (DIS), Tim Hortons (THI), FireEye (FEYE), Groupon (GRPN) Report Street Insider Nov 6
- Trading Radar for 11/04: Hertz Global (HTZ), Kellogg (K), CF Industries (CF), DryShips (DRYS) Report Street Insider Nov 1
- Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call noodls Oct 31
- CORNERSTONE THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Oct 31
CRTX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cornerstone Therapeutics is up 81.64% over the last year vs S&P 500 Total Return up 30.24%, XenoPort down 35.84%, and Targacept up 14.44%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for CRTX
Pro Strategies Featuring CRTX
Did Cornerstone Therapeutics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Cornerstone Therapeutics, Inc., is a specialty pharmaceutical company which commercializes products for the hospital and adjacent specialty markets.